Background: Findings in the literature have been quite conflicting with respect to predicting residual pleural thickening (RPT) in tuberculous pleurisy (TP). The aim of this study was to determine which sonographic feature of TP might help in predicting the development of RPT. Methods: Eighty-seven patients with TP were enrolled prospectively. The initial sonographic features were classified as anechoic, homogenously echogenic, complex non-septated and complex septated. The RPT level was measured 12 months after the start of antituberculosis (TB) treatment. Spirometry was performed 6 and 12 months after the start of anti-TB treatment. Results: A higher odds of an RPT level .10 mm was found in patients with positive TB bacillus culture in pleural fluid (OR, 20.9; 95% CI, 2.2 to 198.0) and a complex septated sonographic pattern (OR, 145.0; 95% CI, 22.3 to 942.3). A complex septated sonographic pattern can predict RPT with a sensitivity of 80%, specificity of 96%, positive predictive value of 84% and negative predictive value of 94%. Patients with an RPT level .10 mm had a lower forced vital capacity than those without (75.4% (9.2%) predicted vs 83.2% (9.5%) predicted, p,0.01) Conclusion: A complex septated sonographic pattern is a useful sign to predict an RPT level .10 mm 1 year after the start of anti-TB treatment. An RPT level .10 mm is associated with a high probability of decreased lung volumes. Therefore, the initial sonographic feature is beneficial in predicting the sequelae of TP after treatment.The incidence rate of tuberculosis (TB) in Taiwan was 67.38 per 100 000 people in 2006.1 Although prevalence and mortality rates have decreased with time owing to effective drug treatment, this infectious disease remains a serious public health issue because of its detrimental complications. Tuberculous pleurisy (TP) is one of the manifestations of TB and is present in 10% of all causes of TB in Taiwan. 2 Although updated therapeutic regimens can effectively control this infectious disease and minimise its sequelae, residual pleural thickening (RPT) has been found in about half of the patients. [3][4][5] We have previously shown that approximately 26% of patients with TP after treatment are complicated with RPT levels .10 mm.6 RPT may result in a decreased lung volume and then have important clinical repercussions. It is therefore important to identify the clinical and functional impairment resulting from RPT in patients with TP receiving anti-TB treatment. Thus, the aim of this prospective study was to investigate if sonographic features can serve as a predictor of patient outcomes 12 months after the start of anti-TB drug treatment. To the best of our knowledge, limited studies have been published regarding the evaluation of RPT and the associated impairment in treated TP patients by using the initial songraphic parameters.